Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1
Progressive supranuclear palsy (PSP) is a neurodegenerative disease characterized by aggregation of Tau, encoded by MAPT. Here, the authors perform an EWAS for PSP in prefrontal lobe tissue and find hypermethylation of DLX1 and its antisense transcript DLX1AS to associate with MAPT expression.
Guardado en:
Autores principales: | Axel Weber, Sigrid C. Schwarz, Jörg Tost, Dietrich Trümbach, Pia Winter, Florence Busato, Pawel Tacik, Anita C. Windhorst, Maud Fagny, Thomas Arzberger, Catriona McLean, John C. van Swieten, Johannes Schwarz, Daniela Vogt Weisenhorn, Wolfgang Wurst, Till Adhikary, Dennis W. Dickson, Günter U. Höglinger, Ulrich Müller |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ec0d1bbe28a5442e9f538934be3dd2f3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Understanding fatigue in progressive supranuclear palsy
por: Jong Hyeon Ahn, et al.
Publicado: (2021) -
A case of atypical progressive supranuclear palsy
por: Spaccavento S, et al.
Publicado: (2013) -
Critical appraisal of the role of davunetide in the treatment of progressive supranuclear palsy
por: Gozes I, et al.
Publicado: (2012) -
Segmental Alterations of the Corpus Callosum in Progressive Supranuclear Palsy: A Multiparametric Magnetic Resonance Imaging Study
por: Lavinia A. Bârlescu, et al.
Publicado: (2021) -
Gait analysis may distinguish progressive supranuclear palsy and Parkinson disease since the earliest stages
por: Marianna Amboni, et al.
Publicado: (2021)